Pharmaceuticals

Global Antiparasitic Drugs Market Report 2026–2035: Key Forecasts and Growth Areas

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the antiparasitic drugs market from 2026–2035 with trusted insights from The Business Research Company

How is the Antiparasitic Drugs Market size predicted to change over the forecast window of 2026–2035?

The antiparasitic drugs market has seen robust expansion in recent years. It is anticipated to increase from $25.58 billion in 2025 to $27.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. This historical growth can be attributed to several factors, such as the increasing occurrence of parasitic diseases, restricted access to modern antiparasitic drugs in developing regions, the customary reliance on monotherapy drugs, a rising need for veterinary care, and a lack of public awareness regarding preventive measures.

The antiparasitic drugs market is poised for significant expansion over the next few years. Its valuation is anticipated to climb to $36.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period can be attributed to several factors, including the increasing adoption of combination therapies, breakthroughs in precision medicine for parasitic infections, a heightened focus on animal health and safeguarding livestock, the broadening of emerging markets, and the creation of innovative delivery systems for antiparasitic medications. Major trends anticipated during this period encompass a growing prevalence of parasitic infections, the development of synergistic antiparasitic drugs, wider applications in animal healthcare, an increasing preference for oral and injectable treatment methods, and the introduction of novel antiparasitic agents.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp

Which Drivers Are Contributing To The Expansion Of The Antiparasitic Drugs Market?

The rising occurrence of vector-borne diseases is projected to drive the growth of the antiparasitic drugs market in the coming period. Vector-borne diseases are defined as infectious conditions transmitted to humans or other animals through the bite of arthropods, primarily insects such as mosquitoes, ticks, and flies. Malaria, dengue, and yellow fever are some examples of these diseases. Antiparasitic drugs are vital in preventing the spread of vector-borne diseases by targeting and eliminating the responsible parasites. Several antiparasitic drugs, including chloroquine, doxycycline, and atovaquone-proguanil, are commonly used for treating malaria. For instance, in June 2024, according to the Centers for Disease Control and Prevention, a US-based Government agency, over 9.7 million dengue cases were reported across the Americas from January to June 2024, which is more than double the 4.6 million cases reported in 2023. Puerto Rico accounted for 1,498 dengue cases in the United States, and 745 cases were identified among U.S. travelers returning from affected areas. Thus, the increasing incidence of vector-borne diseases fuels the growth of the antiparasitic drugs market.

What Segment Classifications Make Up The Antiparasitic Drugs Market?

The antiparasitic drugs market covered in this report is segmented –

1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products

2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Imidazolesthiazoles

3) By Route of Administration: Oral, Injectable, Topical

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel

2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine

3) By Ectoparasiticides: Permethrin, Malathion, Fipronil

4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents

What Industry Trends Are Transforming The Antiparasitic Drugs Market?

Major companies operating in the antiparasitic drugs market are focusing on developing innovative products such as chewable veterinary products to enhance ease of administration and improve pet compliance. Chewable veterinary products are flavored, easy-to-administer tablets or treats designed to deliver medication to animals. They enhance pet compliance by making treatment more palatable and stress-free. For instance, in April 2024, C.H. Boehringer Sohn AG and Co. KG, a Germany-based pharmaceutical company, launched NexGard Spectra to provide comprehensive parasite control. NexGard SPECTRA is a soft, flavorful chew that provides comprehensive internal and external parasite control for dogs, effectively targeting fleas, ticks, heartworms, and various intestinal worms in a single monthly dose. It demonstrates rapid action by killing fleas within four hours of administration and achieving over 99% effectiveness against multiple parasites shortly thereafter.

Which Key Players Are Driving Competition In The Antiparasitic Drugs Market?

Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim Group, Zoetis Inc., Eisai Co. Ltd., Dr. Reddy’s Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Santé Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

Which Region Is Projected To Lead The Antiparasitic Drugs Market During The Forecast Period?

North America was the largest region in the antiparasitic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antiparasitic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Antiparasitic Drugs Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12927&type=smp

Browse Through More Reports Similar to the Global Antiparasitic Drugs Market 2026, By The Business Research Company

Antiparasitic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

Antispasmodics Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report

Anticholinergic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795